Key result
Subacute systolic blood pressure variability linked to ~10% higher odds of poor stroke outcome.
Why the study?
The influence of blood pressure variability on outcomes in patients with severe stroke remains largely unsettled.
Does increased blood pressure variability in the acute and subacute phases predict 90-day poor functional outcome (mRS ≥ 3) in patients with acute severe stroke?
Cohort (n=442)
Yes
Does increased blood pressure variability in the acute and subacute phases predict 90-day poor functional outcome (mRS ≥ 3) in patients with acute severe stroke?
In patients with acute severe stroke, blood pressure variability during the subacute phase (days 2-7)—especially when SBP SD exceeds 12 mmHg—strongly predicts 90-day poor functional outcome, highlighting the need for smooth, sustained BP control while avoiding excessively low SBP.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in severe stroke; leaves open whether stabilizing variability improves outcomes.
The influence of blood pressure variability (BPV) on outcomes in patients with severe stroke is still largely unsettled. Using the data of CHASE trial, the authors calculated the BPV during the acute phase and subacute phase of severe stroke, respectively. The primary outcome was to investigate the relationship between BPV and 90-day modified Rankin scale (mRS) ≥ 3. The BPV was assessed by eight measurements including standard deviation (SD), mean, maximum, minimum, coefficient of variation (CV), successive variation (SV), functional successive variation (FSV), and average real variability (ARV). Then, the SD of SBP was divided into quintiles and compared the quintile using logistic regression in three models. The acute phase included 442 patients, and the subacute phase included 390 patients. After adjustment, six measurements of BPV during the subacute phase rather than acute phase were strongly correlated with outcomes including minimum (odds ratio [OR]: 0.83, 95% confidence interval [CI]: 0.69-0.99, p = .037), SD (OR: 1.10, 95% CI: 1.03-1.17, p = .007), CV (OR: 1.12, 95% CI: 1.03-1.23, p = .012), ARV (OR: 1.13, 95% CI: 1.05-1.20, p < .001), SV (OR: 1.09, 95% CI: 1.04-1.15, p = .001), and FSV (OR: 1.12, 95% CI: 1.05-1.19, p = .001). In the logistic regression, the highest fifth of SD of SBP predicted poor outcome in all three models. In conclusion, the increased BPV was strongly correlated with poor outcomes in the subacute phase of severe stroke, and the magnitude of association was progressively increased when the SD of BP was above 12.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2020) conducted a cohort in Acute severe stroke (ischemic or hemorrhagic) (n=442). Systolic blood pressure variability (standard deviation of SBP in the subacute phase, days 2-7) vs. Lower systolic blood pressure variability (or lowest quintile of SBP standard deviation) was evaluated on 90-day poor functional outcome, defined as modified Rankin scale (mRS) score ≥ 3 (3-6) (OR 1.10, 95% CI 1.03-1.17, p=0.007). Increased systolic blood pressure variability (SD) in the subacute phase was strongly associated with 90-day poor outcome (mRS ≥ 3) in severe stroke patients.
Synapse has enriched 10 related papers. Consider them for comparative context: